Produced in partnership with BlackDoctor.org and the Leukemia & Lymphoma Society.
Supported by GlaxoSmithKline and by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
This activity is not certified for continuing education.
You may not be aware, but research shows that not all patients are benefiting equally from advances in treatment for myeloma. Black patients are at higher risk of developing myeloma but are less likely to be offered new treatments and are also under-represented in clinical trials. To achieve more equal care, we need to work together. The latest findings show better survival when novel therapies are used equitably in patients with myeloma. One of the best ways to help achieve this is through education.
You are invited to join us for the live educational event: “Teaming Up with Your Doctor to Improve Equity in Care for Multiple Myeloma.” A physician, nurse practitioner, and patient advocate will discuss new and emerging treatment options, developing a treatment plan, and clinical-trial eligibility to ensure you are an active participant in decisions with your care team.
Key learning points for this educational session are:
- Understanding racial differences in risk factors, prevalence, treatment, and outcomes of patients with myeloma
- Approved and emerging treatments for newly diagnosed myeloma
- Approved and emerging treatments for relapsed/refractory myeloma
- How to deal with expected side effects of treatment
- What is involved in participating in clinical trials
- Where to find support and resources
Monique Hartley-Brown, MD, MMSc
Attending Physician, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute Assciate Physician Brigham & Women's Hospital Department of Medical Oncology Member of Faculty, Harvard Medical School
Amy Pierre, MSN, RN, ANP-BC
Senior Clinical Director, Real World Evidence Research Organization, Flatiron Health
Nurse Practitioner, Memorial Sloan Kettering Cancer Center
Director, Outreach and Health Promotion
The Leukemia & Lymphoma Society
Interview Participant - Multiple Myeloma Survivor
Interview Participant - Myeloma Survivor